文献速递心脑血管急症重症综合管理与镇静镇痛

全国性病情恶化患者识别标准的引入与全院内心血管并发症减少的关联

State-wide reduction in in-hospital cardiac complications in association with the introduction of a national standard for recognising deteriorating patients.
PubMed 文献 · Resuscitation · 2017-08-30
一句话结论引入全国性病情恶化识别标准后,住院患者心脏骤停和急性冠脉综合征并发症月发生率轨迹下降,80岁以上、女性和外科患者获益最明显。

该研究采用中断时间序列分析,覆盖218家医院469万例住院患者,比较2007年7月1日至2010年6月30日基线期与2013年1月1日至2014年6月30日干预期的心血管并发症月发生率轨迹斜率。干预期前,心律失常并发症率上升,急性冠脉综合征(ACS)和全因死亡率下降,心脏骤停、心力衰竭和肺水肿保持稳定。总体分析提示干预后心脏和ACS并发症率下降,但全院死亡率无显著变化。按年龄分层,80岁以上组心脏骤停(斜率比0.983,95%CI 0.972-0.994)和ACS(0.989,95%CI 0.981-0.997)并发症月率轨迹显著下降;女性心脏骤停(0.985,95%CI 0.977-0.994)、ACS(0.991,95%CI 0.984-0.998)和心力衰竭(0.993,95%CI 0.986-1.000)并发症月率轨迹下降;外科患者心脏骤停(0.983,95%CI 0.969-0.996)、ACS(0.991,95%CI 0.982-1.000)和心律失常(0.996,95%CI 0.994-0.998)并发症显著下降。

要点

  • 全国性病情恶化识别标准引入后,80岁以上患者心脏骤停并发症月率斜率比为0.983(95%CI 0.972-0.994),ACS为0.989(95%CI 0.981-0.997)。
  • 女性患者心脏骤停(斜率比0.985,95%CI 0.977-0.994)、ACS(0.991,95%CI 0.984-0.998)和心力衰竭(0.993,95%CI 0.986-1.000)并发症月率轨迹下降。
  • 外科患者心脏骤停(斜率比0.983,95%CI 0.969-0.996)、ACS(0.991,95%CI 0.982-1.000)和心律失常(0.996,95%CI 0.994-0.998)并发症显著减少。
  • 总体分析提示干预后心脏和ACS并发症率下降,但全院死亡率无显著变化。
  • 干预期前心律失常并发症率上升,ACS和全因死亡率下降,心脏骤停、心力衰竭和肺水肿保持稳定。

适用人群与场景

  • 218家急性医院469万例住院患者,分析住院期间心血管并发症。
  • 按年龄(80岁以上)、性别(女性)和患者类型(外科患者)分层分析。

研究设计与关键结果

  • 研究设计为中断时间序列分析,比较基线期(2007年7月1日至2010年6月30日)与干预期(2013年1月1日至2014年6月30日)的月度并发症率轨迹斜率。
  • 干预期前,心律失常并发症率上升,ACS和全因死亡率下降,心脏骤停、心力衰竭和肺水肿保持稳定。
  • 总体分析提示干预后心脏和ACS并发症率下降,但全院死亡率无显著变化。
  • 80岁以上组心脏骤停斜率比0.983(95%CI 0.972-0.994),ACS斜率比0.989(95%CI 0.981-0.997)。
  • 女性组心脏骤停斜率比0.985(95%CI 0.977-0.994),ACS斜率比0.991(95%CI 0.984-0.998),心力衰竭斜率比0.993(95%CI 0.986-1.000)。
  • 外科患者组心脏骤停斜率比0.983(95%CI 0.969-0.996),ACS斜率比0.991(95%CI 0.982-1.000),心律失常斜率比0.996(95%CI 0.994-0.998)。

证据类型、等级与局限

  • 证据类型:中断时间序列分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,引入全国性病情恶化识别标准与急性医院住院患者心脏骤停和ACS发生率下降相关。
  • 作者认为,80岁以上、女性和外科患者获益最大。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: To examine whether introducing a national standard to improve the recognition of and response to clinical deterioration, was associated with a reduction in cardiovascular events in the hospital environment.

METHOD: Interrupted time series was used to analyse the trajectories of monthly complication rates for 4.69 million admissions in 218 hospitals. Trajectory slopes determined for the "baseline period" (1 July 2007-30 June 2010) and the "Intervention period" (1 January 2013-30 June 2014) were compared (slope ratio).

RESULTS: Before the intervention, complication rates due to arrhythmias were increasing, acute coronary syndrome (ACS) and all-cause mortality decreasing, but were constant for cardiac arrest and heart failure and pulmonary oedema. Analysis of the overall data suggested reduction in the rate of cardiac and ACS complications after the intervention, but no significant change in overall hospital mortality. Analysis by age category showed significant reductions in monthly rate trajectories in the 80 plus years age group for cardiac arrest (slope ratio 0.983, 95% CI: 0.972-0.994) and ACS (0.989, 95% CI: 0.981-0.997) complications. Slope ratios indicating reduced monthly rates were seen in females for cardiac arrest (0.985, 95% CI: 0.977-0.994), ACS (0.991, 95% CI: 0.984-0.998) and heart failure (0.993, 95% CI: 0.986-1.000) complications. There were also significant reductions in cardiac arrest (0.983, 95% CI: 0.969-0.996), ACS (0.991, 95% CI: 0.982-1.000) and arrhythmia (0.996, 95% CI: 0.994-0.998) complications for surgical patients.

CONCLUSIONS: Introduction of a national standard for deteriorating hospitalised patients was associated with a reduction in the rates of in-hospital cardiac arrests and acute coronary syndromes in acute hospitals. Greatest benefit was seen in the elderly, female and surgical patients.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Martin C, Jones D, Wolfe R, et al. State-wide reduction in in-hospital cardiac complications in association with the introduction of a national standard for recognising deteriorating patients. Resuscitation. 2017. PMID: 28860015. doi:10.1016/j.resuscitation.2017.08.240

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。